• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Crispr Therapeutics Ag (NQ: CRSP )

    56.91 -3.57 (-5.90%)
    Streaming Delayed Price Updated: 2:26 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,235,463
    Open 60.84
    Bid (Size) 56.88 (1)
    Ask (Size) 56.97 (4)
    Prev. Close 60.48
    Today's Range 56.84 - 61.47
    52wk Range 37.55 - 91.10
    Shares Outstanding 78,935,098
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Gene Editing Stocks That Could Grow Your Wealth
    Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks. 
    Via InvestorPlace
    3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
    Explore gene-editing stocks with potential to become multibaggers as the industry advances in treating genetic disorders. 
    Via InvestorPlace

    Performance

    YTD
    -13.85%
    -13.85%
    1 Month
    -7.89%
    -7.89%
    3 Month
    +2.43%
    +2.43%
    6 Month
    -6.49%
    -6.49%
    1 Year
    -1.45%
    -1.45%

    More News

    Read More
    Blue Chips, Small Caps Extending Their Breakout
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
    Via The Motley Fool
    1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid
    Via The Motley Fool
    Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
    Via Benzinga
    Topics ETFs
    3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
    Via MarketBeat
    3 Profitable CRISPR Stocks Earning Analysts’ Praise
    Via InvestorPlace
    7 Growth Stocks to Invest $500 In and Cash Out $100K by 2030
    Via InvestorPlace
    The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
    Via InvestorPlace
    The 3 Best Gene Editing Stocks to Buy in July 2024
    Via InvestorPlace
    3 Pharma Stocks Already Ushering in the Next Biotech Boom
    Via InvestorPlace
    3 Top-Rated Gene Editing Stocks Actually Making Money
    Via InvestorPlace
    Trading SMID Biotech Stocks In A Volatile Market
    Via Talk Markets
    You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever.
    Via InvestorPlace
    Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
    Via InvestorPlace
    You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
    Via InvestorPlace
    Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
    Via The Motley Fool
    3 Biotech Stocks That Could Make Your Grandchildren Rich
    Via InvestorPlace
    Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
    Via InvestorPlace
    3 Gene Editing Stocks That Could Make Your Grandchildren Rich
    Via InvestorPlace
    The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom
    Via InvestorPlace
    7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom
    Via InvestorPlace
    Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
    Via The Motley Fool
    Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.